Survival and causes of death among HIV-infected patients starting antiretroviral therapy in north-eastern Vietnam

References

• Reniers G, Araya T, Davey G, Nagelkerke N, Berhane Y, Coutinho R, . Steep declines in population-level AIDS mortality following the introduction of antiretroviral therapy in Addis Ababa, Ethiopia. AIDS 2009;23:511–8.
   Google Scholar
• Lawn S, Myer L, Orrell C, Bekker L, Wood R. Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS 2005;19:2141–8.
   PubMed Web of Science ®Google Scholar
• Ormaasen V, Sandvik L, Dudman SG, Bruun JN. HIV related and non-HIV related mortality before and after the introduction of highly active antiretroviral therapy (HAART) in Norway compared to the general population. Scand J Infect Dis 2007;39:51–7.
   PubMed Web of Science ®Google Scholar
• Etard JF, Ndiaye I, Thierry-Mieg M, Gueye NF, Gueye PM, Laniece I, . Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study. AIDS 2006;20:1181–9.
   PubMed Web of Science ®Google Scholar
• Kumarasamy N, Venkatesh KK, Devaleenol B, Poongulali S, Yephthomi T, Pradeep A, . Factors associated with mortality among HIV-infected patients in the era of highly active antiretroviral therapy in southern India. Int J Infect Dis 2010;14:e127–31.
   Web of Science ®Google Scholar
• Falster K, Choi JY, Donovan B, Duncombe C, Mulhall B, Sowden D, .; Australian HIV Observational Database; TREAT Asia HIV Observational Database. AIDS-related and non-AIDS-related mortality in the Asia-Pacific region in the era of combination antiretroviral treatment. AIDS 2009;13:2323–36.
   Google Scholar
• Vietnam Administration for AIDS Control Ministry of Health. Vietnam HIV/AIDS estimates and projections 2007–2012. VAAC-MoH; 2009. Available at: http://www.unaids.org.vn/sitee/images/stories/EPP%20report%20EN.pdf 24 Sep 2011 (accessed).
   Google Scholar
• Van Tam V, Pharris A, Thorson A, Alfven T, Larsson M. “It is not that I forget, it's just that I don't want other people to know”: barriers to and strategies for adherence to antiretroviral therapy among HIV patients in Northern Vietnam. AIDS Care 2011;23:139–45.
   PubMed Web of Science ®Google Scholar
• Maher L, Coupland H, Musson R. Scaling up HIV treatment care and support for injecting drug users in Vietnam. Int J Drug Policy 2007;18:296–305.
   PubMed Web of Science ®Google Scholar
• Quach L, Mayer K, McGarvey ST, Lurie MN, Do P. Knowledge, attitudes, and practices among physicians on HIV/AIDS in Quang Ninh Vietnam. AIDS Patient Care STDs 2005;19:335–46.
   PubMed Web of Science ®Google Scholar
• Ngo AT, Duc NH, DN, Lan NH, Maynart M, Mayaud C, Quy TH. Mechanisms and causes of death in 143 Vietnamese HIV-infected patients hospitalized for tuberculosis. Rev Pneumol Clin 2007;63:139–46.
   PubMed Web of Science ®Google Scholar
• Louie JK, Chi NH, Thao LT, Quang VM, Campbell J, Chau NV, . Opportunistic infections in hospitalized HIV-infected adults in Ho Chi Minh City Vietnam: a cross-sectional study. Int J STD AIDS 2004;15:758–61.
   PubMed Web of Science ®Google Scholar
• Klotz SA, Nguyen HC, Van Pham T, Nguyen LT, Ngo DT, Vu SN. Clinical features of HIV/AIDS patients presenting to an inner city clinic in Ho Chi Minh City Vietnam. Int J STD AIDS 2007;18:482–5.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Verbal autopsy standard: ascertaining and attributing cause of death. Geneva: WHO; 2007. Available at: http://www.who.int/whosis/mort/verbalautopsy standards/en/ 20 May 2010 (accessed).
   Google Scholar
• Iqbal HS, Balakrishnan P, Cecelia AJ, Solomon S, Kumarasamy N, Madhavan V, . Use of an HIV-1 reverse-transcriptase enzyme-activity assay to measure HIV-1 viral load as a potential alternative to nucleic acid-based assay for monitoring antiretroviral therapy in resource-limited settings. J Med Microbiol 2007;56:1611–4.
   PubMed Web of Science ®Google Scholar
• Lawn SD, Harries AD, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 2008;22:1897–908.
   PubMed Web of Science ®Google Scholar
• Chasombat S, McConnell MS, Siangphoe U, Yuktanont P, Jirawattanapisal T, Fox K, . National expansion of antiretroviral treatment in Thailand 2000–2007: program scale-up and patient outcomes J Acquir Immune Defic Syndr 2009;50:506–12.
   PubMed Web of Science ®Google Scholar
• Leone S, Gregis G, Quinzan G, Velenti D, Cologni G, Soavi L, . Causes of death and risk factors among HIV-infected persons in the HAART era: analysis of a large urban cohort. Infection 2011;39:13–20.
   PubMed Web of Science ®Google Scholar
• Grinsztejn B, Veloso VG, Friedman RK, Moreira RI, Luz PM, Campos DP, . Early mortality and cause of deaths in patients using HAART in Brazil and the United States. AIDS 2009;23:2107–14.
   PubMed Web of Science ®Google Scholar
• Srikantiah P, Ghidinelli M, Bachani D, Chasombat S, Daoni E, Mustikawati DE, . Scale-up of national antiretroviral therapy programs: progress and challenges in the Asia Pacific region. AIDS 2010;24:S62–71.
   Web of Science ®Google Scholar
• Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray A, . Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med 2010;362:697–706.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach: 2010 revision. Geneva: WHO; 2010. Available at: http://www.who.int/hiv/pub/arv/adult2010/en/index.html 9 May 2011 (accessed).
   Google Scholar
• Sterne JA, May M, Costagliola D, de Wolf F, Phillips AN, Harris R, . Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 18;373:1352–63.
   Google Scholar
• Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, . Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365:493–505.
   PubMed Web of Science ®Google Scholar
• Severe P, Jean Juste MA, Ambroise A, Eliacin L, Marchand C, Apollon S, . Early versus standard antiretroviral therapy for HIV-infected adults in Haiti. N Engl J Med 2010;363:257–65.
   PubMed Web of Science ®Google Scholar
• Nakanjako D, Colebunders R, Coutinho AG, Kamya MR. Strategies to optimize HIV treatment outcomes in resource-limited settings. AIDS Rev 2009;11:179–89.
   PubMed Web of Science ®Google Scholar
• Wood E, Kerr T, Zhang R, Guillemi S, Palepu A, Hogg RS, . Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users. HIV Med 2008;9:503–7.
   PubMed Web of Science ®Google Scholar
• Quan VM, Minh NL, Ha TV, Ngoc NP, Vu PT, Celentano DD, . Mortality and HIV transmission among male Vietnamese injection drug users. Addiction 2011;106:583–9.
   PubMed Web of Science ®Google Scholar
• Bontell I, Cuong DD, Agneskog E, Diwan V, Larsson M, Sönnerborg A. Transmitted drug resistance and phylogenetic analysis of HIV CRF01_AE in Northern Vietnam. Infect Genet Evol 2011 May 19. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Le Coeur S, Collins IJ, Pannetier J, Lelièvre E. Gender and access to HIV testing and antiretroviral treatments in Thailand: why do women have more and earlier access? Soc Sci Med 2009;69:846–53.
   PubMed Web of Science ®Google Scholar
• Etienne M, Hossain M, Redfield R, Stafford K, Amoroso A. Indicators of adherence to antiretroviral therapy treatment among HIV/AIDS patients in 5 African countries. J Int Assoc Physicians AIDS Care (Chic) 2010;9:98–103.
   PubMedGoogle Scholar
• Beadsworth MB, Cohen D, Ratcliffe L, Jenkins N, Taylor W, Campbell F, . Autopsies in HIV: still identifying missed diagnoses. Int J STD AIDS 2009;20:84–6.
   PubMed Web of Science ®Google Scholar
• Meintjes G, Lawn SD, Scano F, Maartens G, French MA, Worodria W, . Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis 2008;8:516–23.
   PubMed Web of Science ®Google Scholar
• Le T, Wolbers M, Chi NH, Quang VM, Chinh NT, Huong Lan NP, . Epidemiology, seasonality, and predictors of outcome of AIDS-associated Penicillium marneffei infection in Ho Chi Minh City Viet Nam. Clin Infect Dis 2011;52:945–52.
   PubMed Web of Science ®Google Scholar
• Crum NF, Riffenburgh RH, Wegner S, Agan BK, Tasker SA, Spooner KM, . Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr 2006;41:194–200.
   PubMed Web of Science ®Google Scholar
• Lewden C, Salmon D, Morlat P, Bévilacqua S, Jougla E, Bonnet F, . Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers persistent role of AIDS. Int J Epidemiol 2005;34:121–30.
   PubMed Web of Science ®Google Scholar
• Müller M, Wandel S, Colebunders R, Attia S, Furrer H, Egger M. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis 2010;10:251–61.
   PubMed Web of Science ®Google Scholar
• May M, Boulle A, Phiri S, Messou E, Myer L, Wood R, . Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes. Lancet 2010;376:449–57.
   PubMed Web of Science ®Google Scholar
• Swindells S, Jiang H, Mukherjee AL, Winters M, Bosch RJ, Katzenstein D; Aids Clinical Trials Group. Lower CD4 cell count and higher virus load but not antiretroviral drug resistance are associated with AIDS-defining events and mortality: an ACTG Longitudinal Linked Randomized Trials (ALLRT) analysis. HIV Clin Trials 2011;12:79–88.
   PubMed Web of Science ®Google Scholar
• Lepri AC, Katzenstein TL, Ullum H, Phillips AN, Skinhøj P, Gerstoft J, . The relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infection. AIDS 1998;12:1639–43.
   PubMed Web of Science ®Google Scholar